Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Barclays
Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Sarepta Therapeutics Inc Note 1.250 9/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $524k | 516k | 1.02 |
Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1
View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1